These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 14742206)

  • 1. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
    Alvarez M; Tran JH; Chow N; Jacoby GA
    Antimicrob Agents Chemother; 2004 Feb; 48(2):533-7. PubMed ID: 14742206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae].
    Wang QT; Liu YM; Wang H; Sun HL; Chen MJ; Du XL
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.
    Ding H; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Wang A; Deng Q; Zhang H; Wang C; Liu L; Xu X; Wang L; Shen X
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):915-21. PubMed ID: 18449580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups.
    Castanheira M; Farrell SE; Krause KM; Jones RN; Sader HS
    Antimicrob Agents Chemother; 2014; 58(2):833-8. PubMed ID: 24247134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.
    Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Identification and Genotypic Characterization of Plasmid-Mediated AmpC β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Iran.
    Robatjazi S; Nikkhahi F; Niazadeh M; Amin Marashi SM; Peymani A; Javadi A; Kashani AH
    Curr Microbiol; 2021 Jun; 78(6):2317-2323. PubMed ID: 33837818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
    Sarı AN; Biçmen M; Gülay Z
    Mikrobiyol Bul; 2013 Oct; 47(4):582-91. PubMed ID: 24237427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S; Altanlar N
    Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli and Klebsiella pneumoniae.
    Yilmaz NO; Agus N; Bozcal E; Oner O; Uzel A
    Indian J Med Microbiol; 2013; 31(1):53-9. PubMed ID: 23508430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.
    Lee K; Lee M; Shin JH; Lee MH; Kang SH; Park AJ; Yong D; Chong Y
    Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA; Medeiros AA; Jacoby GA
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.
    Baraniak A; Grabowska A; Izdebski R; Fiett J; Herda M; Bojarska K; Żabicka D; Kania-Pudło M; Młynarczyk G; Żak-Puławska Z; Hryniewicz W; Gniadkowski M;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5493-9. PubMed ID: 21930889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.